Novartis (NVS) Stock: Q125 Earnings Beat Boosts Confidence in Oncology and Cardio Drugs
TLDR Novartis reported Q1 2025 EPS of $2.28, beating expectations by 7.55%. Revenue reached $13.23 billion, surpassing estimates and up 11.9% year over year. Strong...